C17orf98: A Potential Drug Target and Biomarker for Chromosome 17 Open Reading Frame 98

Target Name: C17orf98

NCBI ID: G388381

C17orf98

Other Name(s): chromosome 17 open reading frame 98 | CQ098_HUMAN | Chromosome 17 open reading frame 98 | Uncharacterized protein C17orf98

C17orf98: A Potential Drug Target and Biomarker for Chromosome 17 Open Reading Frame 98

Chromosome 17 (17p) is one of the chromosomes that contribute to the development and aging of an organism. It is home to over 1,000 genes, including those involved in various cellular processes, such as growth, development, and reproduction. Open Reading Frame (ORF) 98, located on chromosome 17p, is a region of DNA that encodes a protein known as TRPV4 (Transient receptor potential cation channel subfamily 4).

TrPV4 is a voltage-dependent cation channel that plays a crucial role in sensory perception and neurotransmission. It is expressed in various tissues, including the brain, and is involved in the regulation of ion channels, which allows it to be a potential drug target for various neurological and psychiatric disorders.

C17orf98 is a gene that encodes a protein similar to TRPV4. It is located on chromosome 17p and has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. The ORF98 gene has also been implicated in various diseases, including cancer.

The potential drug target for C17orf98 is its role in pain perception and neurotransmission. TRPV4 is known to be involved in the regulation of pain perception and neurotransmission, which makes it a potential drug target for pain relief. By targeting TRPV4 with small molecules or other therapeutic agents, researchers may be able to treat various pain-related conditions, including chronic pain and neuropathic pain.

In addition to its potential as a drug target, C17orf98 may also be used as a biomarker for various diseases. The expression of TRPV4 is known to be associated with various diseases, including cancer. By using C17orf98 as a biomarker for disease, researchers may be able to develop more targeted and effective therapies for these diseases.

The C17orf98 gene has also been shown to be involved in the regulation of various cellular processes, including cell adhesion and migration. This suggests that it may be involved in the development and progression of various diseases, including cancer.

In conclusion, C17orf98 is a potential drug target and biomarker for various diseases. Its role in pain perception and neurotransmission, as well as its involvement in the regulation of cellular processes, makes it an attractive target for small molecule-based therapies. Further research is needed to fully understand the potential of C17orf98 as a drug target and biomarker for various diseases.

Protein Name: Chromosome 17 Open Reading Frame 98

The "C17orf98 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C17orf98 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets